Eosinophilic Esophagitis Clinical Therapy Comparison Trial
NCT01821898
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class
Stopped
Recruitment was below expectation
Conditions
Eosinophilic Esophagitis
Interventions
DRUG:
Oral Budesonide
OTHER:
Elimination diet
Sponsor
Baylor College of Medicine